Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells (Q40493795)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

author name string

Julia T Arnold

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hanh Le

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kimberly K McFann

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Marc R Blackman

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

9 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

288

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

E573-84

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Structure and function of the type 1 insulin-like growth factor receptor.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Enzymes of Androgen Formation and Degradation in the Human Prostate

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Dehydroepiandrosterone stimulates the estrogen response element

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Molecular expression of 17 beta hydroxysteroid dehydrogenase types in relation to their activity in intact human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

The IGF axis in the prostate

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

P450-dependent enzymes as targets for prostate cancer therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Adrenal steroids in human prostatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

CYP7B generates a selective estrogen receptor beta agonist in human prostate

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Presence of 5alpha-reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Interaction of Δ5-Androstene-3β,17β-diol with Estradiol and Dihydrotestosterone Receptors in Human Myometrial and Mammary Cancer Tissue1

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

A role for estrogen receptor beta in the regulation of growth of the ventral prostate

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00454.2004

21 January 2018

Identifiers

10.1152/AJPENDO.00454.2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40493795&oldid=1898154736"